Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review

被引：7
作者：
Xing, Lijie [1 ]
He, Qiang [1 ]
Xie, Linna [1 ]
Wang, Hui [1 ]
Li, Zengjun [1 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Dept Hematol, Shandong Canc Hosp & Inst, Jinan, Peoples R China
来源：
HAEMATOLOGICA | 2022年 / 107卷 / 05期
关键词：
CHRONIC LYMPHOCYTIC-LEUKEMIA; IBRUTINIB; THERAPY;
D O I：
10.3324/haematol.2021.280259
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1226 / 1228
页数：3
相关论文
共 15 条
[1]  
Algrin C, 2017, BLOOD, V130
[2]   B-cell Prolymphocytic Leukemia: Case Report and Challenges on a Diagnostic and Therapeutic Forefront [J].
Bindra, Bikramjit S. ;
Kaur, Harpreet ;
Portillo, Shellsea ;
Emiloju, Oluwadunni ;
de de Jesus, Katherine Garcia .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (09)
[3]   Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial [J].
Buehler, A. ;
Wendtner, C-M ;
Kipps, T. J. ;
Rassenti, L. ;
Fraser, G. A. M. ;
Michallet, A-S ;
Hillmen, P. ;
Duerig, J. ;
Gregory, S. A. ;
Kalaycio, M. ;
Aurran-Schleinitz, T. ;
Trentin, L. ;
Gribben, J. G. ;
Chanan-Khan, A. ;
Purse, B. ;
Zhang, J. ;
De Bedout, S. ;
Mei, J. ;
Hallek, M. ;
Stilgenbauer, S. .
BLOOD CANCER JOURNAL, 2016, 6 :e404-e404
[4]   Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter phase II HOVON trial [J].
Chamuleau, Martine E. D. ;
Burggraaff, Coreline N. ;
Nijland, Marcel ;
Bakunina, Katerina ;
Mous, Rogier ;
Lugtenburg, Pieternella J. ;
Dierickx, Daan ;
van Imhoff, Gustaaf W. ;
Vermaat, Joost S. P. ;
Marijt, Eric A. F. ;
Visser, Otto ;
Mandigers, Caroline ;
Bilgin, Yavuz M. ;
Beeker, Aart ;
Durian, Mark F. ;
van Rees, Bas P. ;
Bohmer, Lara H. ;
Tick, Lidwine W. ;
Boersma, Rinske S. ;
Snijders, Tjeerd J. F. ;
Schouten, Harry C. ;
Koene, Harry R. ;
de Jongh, Eva ;
Hijmering, Nathalie ;
Diepstra, Arjan ;
van de Berg, Anke ;
Arens, Anne I. J. ;
Huijbregts, Julia ;
Hoekstra, Otto ;
Zijlstra, Josee M. ;
de Jong, Daphne ;
Kersten, Marie Jose .
HAEMATOLOGICA, 2020, 105 (12) :2805-2812
[5]   B-cell prolymphocytic leukemia successfully treated with B-cell receptor antagonists, but resistant to venetoclax [J].
Christoforidou, Anna ;
Bezirgiannidou, Zoe ;
Vrachiolias, George ;
Papoutselis, Menelaos ;
Spanoudakis, Emmanouil ;
Kotsianidis, Ioannis .
LEUKEMIA & LYMPHOMA, 2020, 61 (03) :749-752
[6]  
Coelho H, 2017, CASE REP HEMATOL, V2017, DOI 10.1155/2017/8563218
[7]   Ibrutinib therapy is effective in B-cell prolymphocytic leukemia exhibiting MYC aberrations [J].
Damlaj, Moussab ;
Al Balwi, Mohammed ;
Al Mugairi, Areej M. .
LEUKEMIA & LYMPHOMA, 2018, 59 (03) :739-742
[8]   Idelalisib-rituximab induces durable remissions in TP53 disrupted B-PLL but results in significant toxicity: updated results of the UK-wide compassionate use programme [J].
Eyre, Toby A. ;
Fox, Christopher P. ;
Boden, Ali ;
Bloor, Adrian ;
Dungawalla, Moez ;
Shankara, Paneesha ;
Went, Richard ;
Schuh, Anna H. .
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (04) :667-671
[9]   Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study [J].
Fink, Anna Maria ;
Bahlo, Jasmin ;
Robrecht, Sandra ;
Al-Sawaf, Othman ;
Aldaoud, Ali ;
Hebart, Holger ;
Jentsch-Ullrich, Kathleen ;
Doerfel, Steffen ;
Fischer, Kirsten ;
Wendtner, Clemens-Martin ;
Noesslinger, Thomas ;
Ghia, Paolo ;
Bosch, Francesc ;
Kater, Arnon P. ;
Dohner, Hartmut ;
Kneba, Michael ;
Kreuzer, Karl-Anton ;
Tausch, Eugen ;
Stilgenbauer, Stephan ;
Ritgen, Matthias ;
Boettcher, Sebastian ;
Eichhorst, Barbara ;
Hallek, Michael .
LANCET HAEMATOLOGY, 2017, 4 (10) :E475-E486
[10]   B-cell prolymphocytic leukaemia with a t(4;14) FGFR3/IGH translocation: response to ibrutinib [J].
George, Philip ;
Brown, Angela ;
Weinkove, Robert .
PATHOLOGY, 2020, 52 (04) :491-492
12